Previous close | 82.37 |
Open | 82.08 |
Bid | 82.68 x N/A |
Ask | 83.39 x N/A |
Day's range | 82.08 - 82.56 |
52-week range | 58.50 - 86.50 |
Volume | |
Avg. volume | 47 |
Market cap | 38.021B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | 26.13 |
EPS (TTM) | 3.16 |
Earnings date | 30 Oct 2024 |
Forward dividend & yield | 0.11 (0.13%) |
Ex-dividend date | 18 Oct 2024 |
1y target est | N/A |
CHICAGO, October 09, 2024--GE HealthCare integrates third party artificial intelligence (AI)-enabled application orchestration feature into True PACS and Centricity PACS. 1 In collaboration with Blackford, the new AI-enabled offerings help radiologists with their workload which could help lead to quicker diagnosis and treatment for patients. The collaboration is intended to offer health care providers an AI-enabled platform with a catalogue of third-party AI applications that span across various
Honeywell announced plans to spin off its advanced materials business into a separate firm, which could be worth billions. HON stock surges.
CHICAGO, October 08, 2024--GE HealthCare (Nasdaq: GEHC) will announce its third quarter 2024 financial results before the market opens on Wednesday, October 30, 2024. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events. The earnings release, accompanying financial information, and webcast replay also wi